Revenue

The medtech giant projects robust growth with an ambitious pipeline, but a high-stakes regulatory showdown over a key acquisition could redefine its future.

Colliers' steady dividend signals deep financial health, but its true strength lies in a diversified model increasingly tied to infrastructure and the energy transition.